Clinical Trial Update: Reducing Total Cardiovascular Risk in an Urban Community [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update aimed at reducing overall cardiovascular risk in an urban community; completed with results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis
• Cardiovascular Diseases
• Cerebral Arteriosclerosis
• Coronary Disease
• Diabetes Mellitus
• Heart Diseases
• Hypertension

Snippet

Sponsor: Johns Hopkins University | Conditions: Cardiovascular Diseases, Heart Diseases | Phase 4 | Status: COMPLETED | Results posted: 2017-09-15